Your browser is no longer supported. Please, upgrade your browser.
BAX Baxter International Inc. daily Stock Chart
Baxter International Inc.
IndexS&P 500 P/E17.47 EPS (ttm)3.36 Insider Own0.10% Shs Outstand542.34M Perf Week2.50%
Market Cap31.80B Forward P/E22.94 EPS next Y2.56 Insider Trans-91.80% Shs Float542.34M Perf Month5.81%
Income1.85B PEG1.35 EPS next Q0.57 Inst Own87.50% Short Float1.66% Perf Quarter16.26%
Sales10.26B P/S3.10 EPS this Y15.80% Inst Trans0.24% Short Ratio2.93 Perf Half Y25.95%
Book/sh16.06 P/B3.65 EPS next Y12.60% ROA11.80% Target Price59.50 Perf Year35.02%
Cash/sh5.27 P/C11.13 EPS next 5Y12.97% ROE21.70% 52W Range42.22 - 59.41 Perf YTD32.25%
Dividend0.64 P/FCF25.59 EPS past 5Y18.40% ROI5.30% 52W High-1.30% Beta0.68
Dividend %1.09% Quick Ratio2.10 Sales past 5Y-6.10% Gross Margin38.80% 52W Low38.89% ATR0.68
Employees48000 Current Ratio2.70 Sales Q/Q4.20% Oper. Margin20.30% RSI (14)74.08 Volatility1.18% 1.06%
OptionableYes Debt/Eq0.32 EPS Q/Q-91.90% Profit Margin18.10% Rel Volume0.65 Prev Close59.14
ShortableYes LT Debt/Eq0.32 EarningsApr 26 BMO Payout15.30% Avg Volume3.08M Price58.64
Recom2.60 SMA203.44% SMA508.13% SMA20019.68% Volume2,014,609 Change-0.85%
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $55 → $58
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $40 → $47
Apr-14-16Upgrade Piper Jaffray Neutral → Overweight
Feb-03-16Reiterated RBC Capital Mkts Sector Perform $37 → $40
Nov-16-15Resumed Piper Jaffray Neutral $90 → $39
Aug-11-15Reiterated Barclays Overweight $43 → $45
Jul-30-15Downgrade Leerink Partners Outperform → Mkt Perform $82 → $40
Jul-13-15Reiterated RBC Capital Mkts Sector Perform $74 → $37
Jul-02-15Reiterated Barclays Overweight $80 → $43
Jul-02-15Downgrade BofA/Merrill Buy → Neutral
Jul-01-15Downgrade Credit Suisse Outperform → Neutral $75 → $39
Jun-24-15Initiated Goldman Buy
May-19-15Reiterated Barclays Overweight $83 → $80
Jan-08-15Reiterated RBC Capital Mkts Sector Perform $72 → $76
Oct-17-14Reiterated RBC Capital Mkts Sector Perform $78 → $72
May-25-17 04:25PM  Tweedy Browne Sells Baxter, Cisco, 3M
11:29AM  Medtronic's focus on surgical products fuels profit beat Reuters
09:30AM featured highlights: Applied Materials, Coherent, Axcelis Technologies, Baxter International, Ultra Clean Holdings, Kelly Services and Ferro Zacks
May-24-17 03:47PM  Fed balance sheet unwind 'absolutely' reduces chance of more rate hikes: Former Dallas Fed advisor CNBC
10:15AM  New Strong Buy Stocks for May 24th Zacks
May-23-17 03:19PM  Can These 3 High-Flying Healthcare Stocks Reach the Clouds? Motley Fool
12:01PM  Alexion stock plummets 9% after top management shake-up MarketWatch
08:30AM  Baxter Presents Data at ISPOR Annual Meeting with Focus on Helping Hospitals Improve Patient Care Business Wire
May-22-17 09:30AM featured highlights: Baxter International, Lantheus Holdings, OraSure Technologies, MAM Software Group and Teradyne Zacks
08:35AM  Quest Diagnostics Poised on Solid Q1 Results Despite Woes Zacks
May-19-17 11:54AM  Baxter International Inc. -- Moody's rates Baxter's new euro notes Baa2; stable outlook Moody's
10:19AM  Medtronic (MDT) RESOLUTE ONYX Meets Primary Study Endpoint Zacks
10:00AM  Commonwealth Fund President, David Blumenthal, MD, MPP, Named 2017 Recipient of the William B. Graham Prize for Health Services Research Business Wire
May-18-17 04:15PM  Baxter to Present at the Goldman Sachs 38th Annual Healthcare Conference Business Wire
09:25AM  Baxter Launches New AK 98 Hemodialysis System Designed to Help Providers Reach Treatment Goals Business Wire
May-17-17 08:59AM  Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive Zacks
May-16-17 04:04PM  Yum Brands, Intuitive Surgical Called Buys; Pfizer Cut To Sell Investor's Business Daily
09:50AM  New Strong Buy Stocks for May 16th Zacks
May-15-17 08:33AM  TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1 Zacks
May-12-17 08:50AM  Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up Zacks
08:47AM  New Strong Buy Stocks for May 12th Zacks
08:23AM  Medtronic (MDT) Wins FDA Approval for CRT-P SureScan Suite Zacks
08:06AM  STERIS (STE) Grapples with Headwinds: Should You Dump? Zacks
May-11-17 10:15AM  Genomic Health (GHDX) Misses Q1 Earnings & Sales Estimates Zacks
10:07AM  Dull Q1 Earnings & Tough Industry Spell Trouble for BioScrip Zacks
08:59AM  Becton (BDX) Announces $4.5B Follow-On Share Offerings Zacks
May-10-17 09:30AM featured highlights: Cohu, Axcelis Technologies, Insight Enterprises, Baxter International and Ultra Clean Holdings Zacks
09:27AM  STERIS (STE) Tops Q4 Earnings & Revenues, Issues '18 View Zacks
09:18AM  Penumbra (PEN) Q1 Loss Wider than Expected, View Intact Zacks
May-09-17 04:20PM  ETFs with exposure to Baxter International, Inc. : May 9, 2017 Capital Cube
01:43PM  PetMed (PETS) Beats Earnings, Revenue Estimates in Q4 Zacks
11:00AM  Baxter Named One of Americas Best Employers by Forbes Magazine for Third Consecutive Year Business Wire
10:02AM  Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View Zacks
09:33AM  Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View Zacks
09:24AM  New Strong Buy Stocks for May 9th Zacks
07:53AM  Phibro (PAHC) Posts In Line Earnings in Q3, Revises View Zacks
May-08-17 11:14AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017 Capital Cube
10:01AM  Align Technology Invisalign Sales Strong, Currency Woes Stay Zacks
09:47AM  Qiagen Banks on Molecular Diagnostic amid Currency Woes Zacks
09:32AM  CVS Down on Weak Earnings, Pharmacy Services Remains Strong Zacks
09:30AM  VWR Corp (VWR) Beats on Q1 Earnings, Awaits Merger Closure Zacks
May-05-17 10:47AM  BioScrip (BIOS) Q1 Loss Narrower than Expected, Sales Miss Zacks
08:29AM  Omnicell (OMCL) Q1 Loss Narrower than Expected, Revenues Lag Zacks
06:44AM  [$$] Justice Department Investigating Baxter Over Saline Shortage The Wall Street Journal
May-04-17 09:30AM featured highlights: Cott, Rogers, Baxter International, MKS Instruments and CSX Zacks
08:57AM  Cardiovascular Systems (CSII) Swings to Earnings in Q3 Zacks
08:54AM  Bruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates Zacks
07:59AM  5 Top Efficient Stocks to Boost Your Portfolio Zacks
May-03-17 07:25PM  5 Skyrocketing Stocks On the Move Zacks
12:23PM  5 Companies Reach Yearly Highs
09:06AM  Bet on Relative Price Performance with These 5 Stocks Zacks
08:40AM  Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View Zacks
08:30AM  Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology Business Wire
May-02-17 10:18AM  Dow's Pfizer Tops Earnings Views, But Sales Come Up Short Investor's Business Daily
08:30AM  Baxter Raises Quarterly Dividend Business Wire
Apr-27-17 09:10PM  Edited Transcript of BAX earnings conference call or presentation 26-Apr-17 12:30pm GMT Thomson Reuters StreetEvents
03:42PM  Baxter International Inc. Continues to Cut Costs and Grow the Bottom Line Motley Fool
Apr-26-17 05:57PM  [$$] Edward Lifesciences helps healthcare stocks extend run Financial Times
11:26AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Baxter International Inc. and Advises Investors with Losses to Contact the Firm Business Wire
10:26AM  Stock Market News for April 26, 2017 Zacks
09:35AM  Baxter International (BAX) Q1 Earnings Beat, FY17 View Up Zacks
08:44AM  Baxter International (BAX) Beats on Earnings And Sales in Q1 Zacks
08:30AM  4 Firms that Could Hike Dividends by Double Digits Next Week
07:22AM  Baxter beats Street 1Q forecasts Associated Press
07:15AM  Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 Business Wire
Apr-25-17 09:09AM  What to Expect from Baxter Internationals 1Q17 Earnings Market Realist
07:39AM  A Look at Baxter Internationals 1Q17 Revenue Estimates Market Realist
Apr-24-17 05:21PM  Baxter International: What Analysts Recommend ahead of Q1 Results Market Realist
12:47PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baxter International, Inc. - BAX Accesswire
Apr-21-17 10:37AM  Will Baxter International (BAX) Disappoint in Q1 Earnings? Zacks
07:54AM  Baxter Launches Drug Library Guide for Smart Infusion System Zacks
07:20AM  Why Is Baxter International (BAX) Up 5.5% Since the Last Earnings Report? Zacks
Apr-20-17 08:30AM  Baxter Introduces Comprehensive Guide for Building a Smart Infusion System Drug Library Business Wire
Apr-19-17 09:13PM  Pfizer subpoenaed in U.S. intravenous saline solution probe Reuters
04:15PM  Baxter to Present at the UBS Global Healthcare Conference Business Wire
03:05PM  Pfizer subpoenaed in U.S. intravenous saline solution probe Reuters
11:24AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Baxter International Inc. Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Baxter International, Inc. (BAX) PR Newswire
Apr-18-17 04:15PM  Baxter to Present at the Bank of America Merrill Lynch Healthcare Conference Business Wire
Apr-17-17 09:22PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Baxter International Inc. and Advises Investors with Losses to Contact the Firm Business Wire
05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baxter International, Inc. - BAX PR Newswire
04:56PM  Shares of IV saline maker Baxter dip after employee gets subpoena about possible price fixing CNBC
Apr-14-17 03:31PM  Baxter faces federal criminal inquiry into IV saline sales MarketWatch
Apr-10-17 07:00AM  These 4 'Rocket Stocks' Look Ready for Blastoff
Apr-07-17 03:55PM  ETFs with exposure to Baxter International, Inc. : April 7, 2017 Capital Cube
Apr-04-17 04:22PM  3 Top Medical Instrument Companies to Buy in 2017 Motley Fool
04:22PM  3 Top Medical Instrument Companies to Buy in 2017
10:40AM  Five Stocks For The Smart Contrarian Investor Forbes
10:40AM  Five Stocks For The Smart Contrarian Investor
Apr-03-17 04:15PM  Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders Business Wire
08:30AM  Baxter Unveils Design Enhancements to FLOSEAL and TISSEEL Hemostatic Agents at AORN Meeting Business Wire
Mar-30-17 04:37PM  Moody's: Outlook for US medical products and devices industry remains stable Moody's
04:37PM  Moody's: Outlook for US medical products and devices industry remains stable
Mar-27-17 10:50AM  Alexion Pharma names former Baxalta chief Ludwig Hantson CEO Reuters
10:50AM  Alexion Pharma names former Baxalta chief Ludwig Hantson CEO
Mar-22-17 04:15PM  Baxter International Inc. to Host First Quarter 2017 Financial Results Conference Call for Investors Business Wire
Mar-20-17 10:20AM  Baxter's Chart Is Still Bullish
10:20AM  Baxter's Chart Is Still Bullish
Mar-15-17 02:05PM  The stock market still isn't accounting for this massive stimulus likely coming from Trump at CNBC
09:00AM  Baxter and the Institute for Safe Medication Practices (ISMP) Address Global Medication Error Prevention Business Wire
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shapazian Carole JDirectorMay 23Sale57.922,618151,6359,848May 24 05:00 PM
Shapazian Carole JDirectorMay 09Option Exercise33.773,760126,97516,226May 10 04:16 PM
Shapazian Carole JDirectorMay 09Sale55.893,760210,14612,466May 10 04:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Option Exercise36.71130,7324,799,204176,148May 09 05:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Sale55.69130,7327,280,46545,416May 09 05:16 PM
STALLKAMP THOMAS TDirectorMay 05Option Exercise28.698,080231,82215,593May 09 04:25 PM
STALLKAMP THOMAS TDirectorMay 05Sale55.7610,698596,49011,273May 09 04:25 PM
STROUCKEN ALBERT P LDirectorApr 10Option Exercise30.734,280131,52425,667Apr 12 06:01 PM
STROUCKEN ALBERT P LDirectorApr 10Sale52.804,280225,98421,387Apr 12 06:01 PM
GAVIN JAMES R IIIDirectorMar 29Option Exercise30.734,280131,52434,980Mar 30 04:12 PM
GAVIN JAMES R IIIDirectorMar 29Sale51.724,280221,36230,700Mar 30 04:12 PM
Third Point LLCDirectorFeb 28Sale50.355,901,767297,153,96846,001,790Mar 01 11:25 AM
HELLMAN PETER SDirectorFeb 22Option Exercise30.734,280131,52424,420Feb 23 04:23 PM
HELLMAN PETER SDirectorFeb 22Sale49.814,280213,18720,140Feb 23 04:23 PM
FORSYTH JOHN DDirectorFeb 08Option Exercise30.734,280131,52431,338Feb 10 04:02 PM
FORSYTH JOHN DDirectorFeb 08Sale48.354,280206,93827,058Feb 10 04:02 PM
Shapazian Carole JDirectorFeb 06Option Exercise30.734,280131,52413,507Feb 08 04:14 PM
Shapazian Carole JDirectorFeb 06Sale48.234,280206,4249,227Feb 08 04:14 PM
STORM KORNELIS J.DirectorNov 18Option Exercise30.734,280131,52425,208Nov 22 04:27 PM
STORM KORNELIS J.DirectorNov 18Sale47.104,280201,58820,928Nov 22 04:27 PM